《抗菌试剂及化学方法》.2006年.第4期

......

• Activity and Mechanism of Action of N-Methanocarbathymidine against Herpesvirus and Orthopoxvirus Infections
• Antimalarial Activity of a Synthetic Endoperoxide(RBx-11160/OZ277) against Plasmodium falciparum Isolates from Gabon
• Adding Selectivity to Antimicrobial Peptides: Rational Design of a Multidomain Peptide against Pseudomonas spp
• Activity of Cecropin A-Melittin Hybrid Peptides against Colistin-Resistant Clinical Strains of Acinetobacter baumannii: Molecular Basis for
• Autolytic Properties of Glycopeptide-Intermediate Staphylococcus aureus Mu50
• Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis
• Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure-Activity Relationship, and Q
• Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates
• Binding of Neomycin-Class Aminoglycoside Antibiotics to Mutant Ribosomes with Alterations in the A Site of 16S rRNA
• Bac 32, a Novel Bacteriocin Widely Disseminated among Clinical Isolates of Enterococcus faecium
• Comparing Gatifloxacin and Clarithromycin in Pneumonia Symptom Resolution and Process of Care
• Comparative Pharmacokinetics and Pharmacodynamic Target Attainment of Ertapenem in Normal-Weight, Obese, and Extremely Obese Adults
• Clinical and Economic Impact of Bacteremia with Extended- Spectrum-?-Lactamase-Producing Enterobacteriaceae
• Distribution of Florfenicol Resistance Genes fexA and cfr among Chloramphenicol-Resistant Staphylococcus Isolates
• Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients
• Contribution of rpoB2 RNA Polymerase ? Subunit Gene to Rifampin Resistance in Nocardia Species
• Ether Lipid Ester Derivatives of Cidofovir Inhibit Polyomavirus BK Replication In Vitro
• Efficacy of Hospital Germicides against Adenovirus 8, a Common Cause of Epidemic Keratoconjunctivitis in Health Care Facilities
• Effect of Farnesol on Staphylococcus aureus Biofilm Formation and Antimicrobial Susceptibility
• Gatifloxacin Resistance and Mutations in gyrA after Unsuccessful Helicobacter pylori Eradication in Japan
• Garenoxacin Treatment of Experimental Endocarditis Caused by Viridans Group Streptococci
• Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome
• Gentamicin Causes Apoptosis at Low Concentrations in Renal LLC-PK1 Cells Subjected to Electroporation
• Genetic Structures at the Origin of Acquisition and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene blaOXA-58 in Acinetobacter ba
• Genetic Basis of Tetracycline and Minocycline Resistance in Potentially Probiotic Lactobacillus plantarum Strain CCUG 43738
• Impact of Enterococcus faecalis on the Bactericidal Activities of Arbekacin, Daptomycin, Linezolid, and Tigecycline against Methicillin-Resi
• Immunotherapy with Tacrolimus(FK506) Does Not Select for Resistance to Calcineurin Inhibitors in Candida albicans Isolates from Liver Trans
• Good Clinical Outcomes but High Rates of Adverse Reactions during Linezolid Therapy for Serious Infections: a Proposed Protocol for Monitori
• In Vitro Analysis of ISEcp1B-Mediated Mobilization of Naturally Occurring ?-Lactamase Gene blaCTX-M of Kluyvera ascorbata
• In Vitro Activity of Tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis
• Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac Surgery
• In Vivo Efficacy of Aerosolized Nanostructured Itraconazole Formulations for Prevention of Invasive Pulmonary Aspergillosis
• In Vivo Selection of Fluoroquinolone-Resistant Escherichia coli Isolates Expressing Plasmid-Mediated Quinolone Resistance and Expanded-Spect
• In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class
• Insights into In Vivo Activities of Lantibiotics from Gallidermin and Epidermin Mode-of-Action Studies
• Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin
• Interaction of Pleuromutilin Derivatives with the Ribosomal Peptidyl Transferase Center
• Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa
• Maribavir Pharmacokinetics and the Effects of Multiple-Dose Maribavir on Cytochrome P450(CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-Ac
• Large Conjugative Plasmids from Clinical Strains of Salmonella enterica Serovar Virchow Contain a Class 2 Integron in Addition to Class 1 In
• Lactamase Nomenclature
• Multidimensional Volumetric Imaging of Pulmonary Infiltrates for Measuring Therapeutic Response to Antifungal Therapy in Experimental Invasi
• Microflora Changes with Norfloxacin and Pivmecillinam in Women with Recurrent Urinary Tract Infection
• MepR, a Repressor of the Staphylococcus aureus MATE Family Multidrug Efflux Pump MepA, Is a Substrate-Responsive Regulatory Protein
• New Real-Time PCR Assay Using Locked Nucleic Acid Probes To Assess Prevalence of ParC Mutations in Fluoroquinolone-Susceptible Streptococcus
• New Approach for High-Throughput Screening of Drug Activity on Plasmodium Liver Stages
• Nanodisk-Associated Amphotericin B Clears Leishmania major Cutaneous Infection in Susceptible BALB/c Mice
• Overexpression of the MDR1 Gene Is Sufficient To Confer Increased Resistance to Toxic Compounds in Candida albicans
• Organization of Tn2610 Containing Two Transposition Modules
• Novel Carbapenem-Hydrolyzing Oxacillinase OXA-62 from Pandoraea pnomenusa
• Phosphorothioate Oligonucleotides Inhibit Human Immunodeficiency Virus Type 1 Fusion by Blocking gp41 Core Formation
• Pharmacokinetics of Tenofovir Disoproxil Fumarate and Ritonavir-Boosted Saquinavir Mesylate Administered Alone or in Combination at Steady S
• Pharmacodynamics of a New Cephalosporin, PPI-0903(TAK-599), Active against Methicillin-Resistant Staphylococcus aureus in Murine Thigh and
• Voriconazole Therapeutic Drug Monitoring
• Variability in the Region Downstream of the blaCMY-2 ?-Lactamase Gene in Escherichia coli and Salmonella enterica Plasmids
• Plasmodium falciparum In Vitro Susceptibility to Antimalarial Drugs in Casamance(Southwestern Senegal) during the First 5 Years of Routine
• Preclinical Evaluation of Synthetic –2 RANTES as a Candidate Vaginal Microbicide To Target CCR5
• Protease-Stable Polycationic Photosensitizer Conjugates between Polyethyleneimine and Chlorin(e6) for Broad-Spectrum Antimicrobial Photoinac
• Prevalence of First-Step Mutants among Levofloxacin-Susceptible Invasive Isolates of Streptococcus pneumoniae in the United States
• Rapid Microbiologic and Pharmacologic Evaluation of Experimental Compounds against Mycobacterium tuberculosis
• Quadruple Mutations in Dihydrofolate Reductase of Plasmodium falciparum Isolates from Car Nicobar Island, India
• qnrB, Another Plasmid-Mediated Gene for Quinolone Resistance
• Screen for Inhibitors of the Coupled Transglycosylase-Transpeptidase of Peptidoglycan Biosynthesis in Escherichia coli
• Ritonavir Increases Plasma Amprenavir(APV) Exposure to a Similar Extent when Coadministered with either Fosamprenavir or APV
• Real-Time Reverse Transcription-PCR Quantification of Cytokine mRNA Expression in Golden Syrian Hamster Infected with Leishmania infantum an
• Staphylococcus aureus CcpA Affects Virulence Determinant Production and Antibiotic Resistance
• Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus Infection
• Sequential or Combination Antifungal Therapy with Voriconazole and Liposomal Amphotericin B in a Guinea Pig Model of Invasive Aspergillosis
• Structure-Activity Relationships of Aminocoumarin-Type Gyrase and Topoisomerase IV Inhibitors Obtained by Combinatorial Biosynthesis
• Time Course of Microbiologic Outcome and Gene Expression in Candida albicans during and following In Vitro and In Vivo Exposure to Fluconazo
• The Antimicrobial Peptide Polyphemusin Localizes to the Cytoplasm of Escherichia coli following Treatment
• Substrate Envelope and Drug Resistance: Crystal Structure of RO1 in Complex with Wild-Type Human Immunodeficiency Virus Type 1 Protease
• Using Bacteriophages To Reduce Formation of Catheter-Associated Biofilms by Staphylococcus epidermidis
• Triaryl Pyrazoline Compound Inhibits Flavivirus RNA Replication